A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma
Phase of Trial: Phase I
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Poly ICLC (Primary) ; Melanoma vaccine
- Indications Malignant melanoma
- Focus Adverse reactions
- 05 Jul 2017 According to a Neon Therapeutics media release, initial results from the study have been published in Nature.
- 26 Feb 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 06 Nov 2013 New trial record